Cargando…

Clinicopathological characteristics of extranodal follicular dendritic cell sarcoma: A report of two cases

Follicular dendritic cell sarcoma (FDCS) is an extremely rare tumor, which mainly originates from FDCs in the lymph nodes. Sometimes FDCS can arise from outside the lymph nodes due to the existence of acquired lymphoid tissue, which becomes the histological basis of the tumor. The diagnosis of FDCS,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xing, Sun, Dayong, Zhang, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816366/
https://www.ncbi.nlm.nih.gov/pubmed/33574921
http://dx.doi.org/10.3892/ol.2021.12443
_version_ 1783638427572371456
author Zhao, Xing
Sun, Dayong
Zhang, Gang
author_facet Zhao, Xing
Sun, Dayong
Zhang, Gang
author_sort Zhao, Xing
collection PubMed
description Follicular dendritic cell sarcoma (FDCS) is an extremely rare tumor, which mainly originates from FDCs in the lymph nodes. Sometimes FDCS can arise from outside the lymph nodes due to the existence of acquired lymphoid tissue, which becomes the histological basis of the tumor. The diagnosis of FDCS, particularly extranodal FDCS, presents a challenge for pathologists and hematopathologists. The present study presents two cases of extranodal FDCS based on clinical features and histomorphology. Soft tissue of the chest wall was involved in case 1 and right tonsil tissue in case 2. Case 1 underwent surgery, and was in good health post-operatively. During the 5-month post-operative follow-up period, the patient was healthy in all respects. Case 2 received surgery combined with radiotherapy, and the follow-up data reported that the patient remained alive, without signs of recurrence or metastasis during the 4-month post-operative follow-up period. Additionally, a total of 102 cases of extranodal FDCS were retrieved from the literature, which were extracted and reviewed carefully. The rates of recurrence, metastasis and mortality were 14.63 (12/82), 17.07 (14/82) and 8.29% (15/82), respectively. The overall survival rates of the 102 cases, showing 2-year total survival rates, were 70%, the same with that of 5-year total survival rates. The 2-year tumor-free total survival rates were 68%, and the 5-year equivalents were 32%. Female patients had a poorer prognosis than male patients (P<0.05). Kaplan-Meier estimation presented no statistically significant differences between disease-free survival rates or overall survival rates and age, tumor size or treatment (P>0.05).
format Online
Article
Text
id pubmed-7816366
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-78163662021-02-10 Clinicopathological characteristics of extranodal follicular dendritic cell sarcoma: A report of two cases Zhao, Xing Sun, Dayong Zhang, Gang Oncol Lett Articles Follicular dendritic cell sarcoma (FDCS) is an extremely rare tumor, which mainly originates from FDCs in the lymph nodes. Sometimes FDCS can arise from outside the lymph nodes due to the existence of acquired lymphoid tissue, which becomes the histological basis of the tumor. The diagnosis of FDCS, particularly extranodal FDCS, presents a challenge for pathologists and hematopathologists. The present study presents two cases of extranodal FDCS based on clinical features and histomorphology. Soft tissue of the chest wall was involved in case 1 and right tonsil tissue in case 2. Case 1 underwent surgery, and was in good health post-operatively. During the 5-month post-operative follow-up period, the patient was healthy in all respects. Case 2 received surgery combined with radiotherapy, and the follow-up data reported that the patient remained alive, without signs of recurrence or metastasis during the 4-month post-operative follow-up period. Additionally, a total of 102 cases of extranodal FDCS were retrieved from the literature, which were extracted and reviewed carefully. The rates of recurrence, metastasis and mortality were 14.63 (12/82), 17.07 (14/82) and 8.29% (15/82), respectively. The overall survival rates of the 102 cases, showing 2-year total survival rates, were 70%, the same with that of 5-year total survival rates. The 2-year tumor-free total survival rates were 68%, and the 5-year equivalents were 32%. Female patients had a poorer prognosis than male patients (P<0.05). Kaplan-Meier estimation presented no statistically significant differences between disease-free survival rates or overall survival rates and age, tumor size or treatment (P>0.05). D.A. Spandidos 2021-03 2021-01-06 /pmc/articles/PMC7816366/ /pubmed/33574921 http://dx.doi.org/10.3892/ol.2021.12443 Text en Copyright: © Zhao et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Zhao, Xing
Sun, Dayong
Zhang, Gang
Clinicopathological characteristics of extranodal follicular dendritic cell sarcoma: A report of two cases
title Clinicopathological characteristics of extranodal follicular dendritic cell sarcoma: A report of two cases
title_full Clinicopathological characteristics of extranodal follicular dendritic cell sarcoma: A report of two cases
title_fullStr Clinicopathological characteristics of extranodal follicular dendritic cell sarcoma: A report of two cases
title_full_unstemmed Clinicopathological characteristics of extranodal follicular dendritic cell sarcoma: A report of two cases
title_short Clinicopathological characteristics of extranodal follicular dendritic cell sarcoma: A report of two cases
title_sort clinicopathological characteristics of extranodal follicular dendritic cell sarcoma: a report of two cases
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816366/
https://www.ncbi.nlm.nih.gov/pubmed/33574921
http://dx.doi.org/10.3892/ol.2021.12443
work_keys_str_mv AT zhaoxing clinicopathologicalcharacteristicsofextranodalfolliculardendriticcellsarcomaareportoftwocases
AT sundayong clinicopathologicalcharacteristicsofextranodalfolliculardendriticcellsarcomaareportoftwocases
AT zhanggang clinicopathologicalcharacteristicsofextranodalfolliculardendriticcellsarcomaareportoftwocases